v2.4.0.6
MERGER WITH THE PPG CHEMICALS BUSINESS (Tables)
3 Months Ended
Mar. 31, 2013
MERGER WITH THE PPG CHEMICALS BUSINESS  
Schedule of allocation of the purchase price to assets acquired and liabilities assumed

 

(In millions)
   
 

Cash and cash equivalents

  $ 26.7  

Receivables

    236.7  

Inventories

    72.0  

Prepaid expenses and other

    11.9  

Property, plant and equipment

    957.3  

Goodwill

    1,454.3  

Intangible assets

    1,224.2  

Other assets

    42.5  

Accounts payable

    (97.8 )

Income taxes payable

    (4.7 )

Accrued compensation

    (20.6 )

Other accrued taxes

    (12.1 )

Other accrued liabilities

    (58.0 )

Deferred income taxes

    (614.9 )

Noncurrent pension and other postretirement benefits

    (279.0 )

Other non-current liabilities

    (67.9 )

Debt assumed

    (967.0 )

Noncontrolling interest

    (130.3 )
       

Total net assets acquired

  $ 1,773.3  
       
Schedule of pro forma information

 

 

 
  Three Months Ended March 31,  
In millions, except per share data
  2013   2012  

Net sales

  $ 1,168.9   $ 1,271.3  

Net income (loss) attributable to Axiall

  $ (10.3 )(a) $ 68.4 (b)

Earnings (loss) per share attributable to Axiall:

             

Basic

  $ (0.15 ) $ 0.98  

Diluted

  $ (0.15 ) $ 0.97  

(a)  In addition to the normal pro forma adjustments associated with the Transactions, this amount excludes; (i) the $23.5 million gain on acquisition of controlling interest in PHH; (ii) $10.2 million related to the inventory fair value purchase accounting adjustment; and (iii) $11.0 million related to the expensing of financing fees related to a $688.0 million bridge loan used in the Transactions. These amounts are excluded from the pro forma amounts for the three months ended March 31, 2013 and comparable amounts are included in the three months ended March 31, 2012 to reflect our consolidated results as if the Transactions had taken place on January 1, 2012.

(b)  In addition to the normal pro forma adjustments associated with the Transactions, this amount includes; (i) the $23.5 million gain on acquisition of controlling interest in PHH; (ii) $13.4 million related to the inventory fair value purchase accounting adjustment; and (iii) $11.0 million related to the expensing of financing fees related to a $688.0 million bridge loan used in the Transactions. These amounts are excluded from the pro forma amounts for the three months ended March 31, 2013 and included in the three months ended March 31, 2012 to reflect our consolidated results as if the Transactions had taken place on January 1, 2012.